106 related articles for article (PubMed ID: 18508947)
21. The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis.
Schmidt BM; Kusma M; Feuring M; Timmer WE; Neuhäuser M; Bethke T; Stuck BA; Hörmann K; Wehling M
J Allergy Clin Immunol; 2001 Oct; 108(4):530-6. PubMed ID: 11590377
[TBL] [Abstract][Full Text] [Related]
22. Lack of pharmacokinetic and pharmacodynamic interactions of roflumilast with (R, S)-warfarin in healthy adult subjects.
McCracken N; Lahu G; Bethke TD
Int J Clin Pharmacol Ther; 2011 Jun; 49(6):388-96. PubMed ID: 21612746
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of single- and multiple-dose roflumilast: an open-label, three-way crossover study in healthy Chinese volunteers.
Huang J; Fu CX; Yang XY; Cui C; Yang S; Kuang Y; Guo CX; Hu P; Pei Q; Yang GP
Drug Des Devel Ther; 2018; 12():4047-4057. PubMed ID: 30538429
[TBL] [Abstract][Full Text] [Related]
24. Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects.
Nassr N; Huennemeyer A; Herzog R; von Richter O; Hermann R; Koch M; Duffy K; Zech K; Lahu G
Br J Clin Pharmacol; 2009 Oct; 68(4):580-7. PubMed ID: 19843061
[TBL] [Abstract][Full Text] [Related]
25. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
[TBL] [Abstract][Full Text] [Related]
26. No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study.
de Mey C; Nassr N; Lahu G
BMC Clin Pharmacol; 2011 Jun; 11():7. PubMed ID: 21631929
[TBL] [Abstract][Full Text] [Related]
27. Effect of steady-state enoxacin on single-dose pharmacokinetics of roflumilast and roflumilast N-oxide.
Lahu G; Nassr N; Herzog R; Elmlinger M; Ruth P; Hinder M; Huennemeyer A
J Clin Pharmacol; 2011 Apr; 51(4):586-93. PubMed ID: 20466871
[TBL] [Abstract][Full Text] [Related]
28. High absolute bioavailability of the new oral phosphodiesterase-4 inhibitor roflumilast.
Bethke TD; Lahu G
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):51-7. PubMed ID: 21176727
[TBL] [Abstract][Full Text] [Related]
29. Effect of single and repeated doses of ketoconazole on the pharmacokinetics of roflumilast and roflumilast N-oxide.
Lahu G; Huennemeyer A; von Richter O; Hermann R; Herzog R; McCracken N; Zech K
J Clin Pharmacol; 2008 Nov; 48(11):1339-49. PubMed ID: 18757786
[TBL] [Abstract][Full Text] [Related]
30. Roflumilast for the treatment of chronic obstructive pulmonary disease.
Rabe KF
Expert Rev Respir Med; 2010 Oct; 4(5):543-55. PubMed ID: 20649375
[TBL] [Abstract][Full Text] [Related]
31. Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects.
Nassr N; Lahu G; von Richter O; Reutter F; Knoerzer D; Zech K; Erb KA; Schug B; Blume H; Hermann R
Br J Clin Pharmacol; 2007 Mar; 63(3):365-70. PubMed ID: 16981901
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
33. Study investigating pharmacokinetic interaction between theophylline and roflumilast in healthy adults.
Böhmer G; Gleiter CH; Hünnemeyer A; Lahu G; Bethke TD
Int J Clin Pharmacol Ther; 2011 Jul; 49(7):451-60. PubMed ID: 21726496
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa).
Zhang TT; Song M; Hang TJ; Xu XF; Wen AD; Yang L; Jia L
J Clin Pharm Ther; 2009 Jun; 34(3):345-54. PubMed ID: 19646081
[TBL] [Abstract][Full Text] [Related]
35. Supra-therapeutic doses of roflumilast have no effect on cardiac repolarization in healthy subjects.
Huennemeyer A; Nassr N; Bredenbröker D; Lahu G
Expert Opin Drug Saf; 2011 Jul; 10(4):509-19. PubMed ID: 21585288
[TBL] [Abstract][Full Text] [Related]
36. Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea.
Kim BH; Yi S; Kim J; Lim KS; Kim KP; Lee B; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Jun; 31(6):1234-43. PubMed ID: 19695390
[TBL] [Abstract][Full Text] [Related]
37. Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.
Abdel-Rahman SM; Benziger DP; Jacobs RF; Jafri HS; Hong EF; Kearns GL
Pediatr Infect Dis J; 2008 Apr; 27(4):330-4. PubMed ID: 18316988
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
39. [Intractable diarrhoea and severe weight loss by roflumilast].
Horna O; Toyas C
Med Clin (Barc); 2013 Aug; 141(3):116-8. PubMed ID: 23768858
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults.
Baldwin JR; Fleishaker JC; Azie NE; Carel BJ
Cephalalgia; 2004 Apr; 24(4):288-92. PubMed ID: 15030538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
